Back to Search
DIANA SANTINI, MD
MD
Internal Medicine Physician
NPI: 1790873073IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
158239(NY)
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
HARVARD MEDICAL SCHOOL
Class of 1981
Research & Publications (20)
Serum determination of CA 19-9 in diagnosing pancreatic cancer: an obituary.
PMID 19473891·Dig Liver Dis·2010
8-other
Severe esophagitis in a patient with gastrointestinal stromal tumor treated with imatinib.
PMID 19319786·Endoscopy·2009
5-case
Sclerosing cholangitis, autoimmune chronic pancreatitis, and situs viscerum inversus totalis.
PMID 19307933·Pancreas·2009
5-case
Do we need biopsies of metastases for colorectal cancer patients?
PMID 19584870·Br J Cancer·2009
8-other
High prevalence of retinoblastoma protein loss in triple-negative breast cancers and its association with a good prognosis in patients treated with adjuvant chemotherapy.
PMID 19556322·Ann Oncol·2009
8-other
Cigarettes smoking habit may reduce benefit from cetuximab-based treatment in advanced colorectal cancer patients.
PMID 19534585·Expert Opin Biol Ther·2009
8-other
Cyr61 downmodulation potentiates the anticancer effects of zoledronic acid in androgen-independent prostate cancer cells.
PMID 19530242·Int J Cancer·2009
8-other
Chemo-immunotherapy: a new option for non-small cell lung cancer.
PMID 19242127·Cancer Biol Ther·2009
8-other
Classification of biliary tract cancer (BTC): evaluation of all entities.
PMID 19465430·Ann Oncol·2009
8-other
PTEN expression and KRAS mutations on primary tumors and metastases in the prediction of benefit from cetuximab plus irinotecan for patients with metastatic colorectal cancer.
PMID 19398573·J Clin Oncol·2009
4-observational
NOD2/CARD15 polymorphisms impair innate immunity and increase susceptibility to gastric cancer in an Italian population.
PMID 19397946·Hum Immunol·2009
8-other
KRAS mutations and sensitivity to anti-EGFR monoclonal antibodies in metastatic colorectal carcinoma: an open issue.
PMID 19368524·Expert Opin Biol Ther·2009
6-review
Medical oncology: zoledronic acid prevents bone loss in early-stage breast cancer.
PMID 19333223·Nat Rev Clin Oncol·2009
6-review
KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer.
PMID 19603018·Br J Cancer·2009
8-other
MUC2 but not MUC5 expression correlates with prognosis in radically resected pancreatic cancer patients.
PMID 19587537·Cancer Biol Ther·2009
8-other
Chronic asymptomatic pancreatic hyperenzymemia is a benign condition in only half of the cases: a prospective study.
PMID 19296399·Scand J Gastroenterol·2009
8-other
Outcome of conservatively treated microinvasive squamous cell carcinoma of the uterine cervix during a 10-year follow-up.
PMID 19258938·Int J Gynecol Cancer·2009
8-other
Value of both WHO and TNM classification systems for patients with pancreatic endocrine tumors: results of a single-center series.
PMID 19655196·World J Surg·2009
8-other
Insulin-like growth factor 1 receptor expression in wild-type GISTs: a potential novel therapeutic target.
PMID 19672856·Int J Cancer·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 505 E 70TH ST # HT-4
NEW YORK, NY 10021 - Phone
- (212) 746-2875
Quick Facts
- NPI
- 1790873073
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 45
- Publications
- 20
Are you this provider?
Claim Your Profile